UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

HDL particle number and size as predictors of cardiovascular disease

Frontiers in pharmacology, 2015-10, Vol.6, p.218-218

Kontush, Anatol

2015

Volltextzugriff (PDF)

Functionally defective high-density lipoprotein: a new therapeutic target at the crossroads of dyslipidemia, inflammation, and atherosclerosis

Pharmacological reviews, 2006-09, Vol.58 (3), p.342-374

2006

Volltextzugriff (PDF)

Antiatherogenic function of HDL particle subpopulations: focus on antioxidative activities

Current opinion in lipidology, 2010-08, Vol.21 (4), p.312-318

2010

Volltextzugriff (PDF)

HDL and Reverse Remnant-Cholesterol Transport (RRT): Relevance to Cardiovascular Disease

Trends in molecular medicine, 2020-12, Vol.26 (12), p.1086-1100

Kontush, Anatol

2020

Volltextzugriff (PDF)

Phosphatidylserine in atherosclerosis

Current opinion in lipidology, 2016-08, Vol.27 (4), p.414-420

2016

Volltextzugriff (PDF)

Dysfunctional HDL and atherosclerotic cardiovascular disease

Nature reviews cardiology, 2016-01, Vol.13 (1), p.48-60

2016

Volltextzugriff (PDF)

Cholesterol, Lipoproteins, and Cardiovascular Health: Separating the Good (HDL), the Bad (LDL), and the Remnant

Kontush, Anatol

1, 2024

Volltextzugriff (PDF)

HDL Particle Size Is a Critical Determinant of ABCA1-Mediated Macrophage Cellular Cholesterol Export

Circulation research, 2015-03, Vol.116 (7), p.1133-1142

2015

Volltextzugriff (PDF)

High-density lipoproteins: A consensus statement from the National Lipid Association

Journal of clinical lipidology, 2013-09, Vol.7 (5), p.484-525

2013

Volltextzugriff (PDF)

HDL-Targeting Therapeutics: Past, Present and Future

Current pharmaceutical design, 2017-01, Vol.23 (8), p.1207-1215

2017

Volltextzugriff (PDF)

Pleiotropic effects of apolipoprotein C3 on HDL functionality and adipose tissue metabolic activity[S]

Journal of lipid research, 2017-09, Vol.58 (9), p.1869-1883

2017

Volltextzugriff (PDF)

HDL Measures, Particle Heterogeneity, Proposed Nomenclature, and Relation to Atherosclerotic Cardiovascular Events

Clinical chemistry (Baltimore, Md.), 2011-03, Vol.57 (3), p.392-410

2011

Volltextzugriff (PDF)

Antiatherogenic small, dense HDL-guardian angel of the arterial wall?

Nature clinical practice cardiovascular medicine, 2006-03, Vol.3 (3), p.144-153

2006

Volltextzugriff (PDF)

Circulating phospholipid profiling identifies portal contribution to NASH signature in obesity

Journal of hepatology, 2015-04, Vol.62 (4), p.905-912

2015

Volltextzugriff (PDF)

Small dense HDLs display potent vasorelaxing activity, reflecting their elevated content of sphingosine-1-phosphate

Journal of lipid research, 2018-01, Vol.59 (1), p.25-34

2018

Volltextzugriff (PDF)

Functionality of HDL: antioxidation and detoxifying effects

Handbook of experimental pharmacology, 2015-01, Vol.224, p.207

2015

Volltextzugriff (PDF)

Apolipoprotein A-I structural organization in high-density lipoproteins isolated from human plasma

Nature structural & molecular biology, 2011-04, Vol.18 (4), p.416-422

2011

Volltextzugriff (PDF)

Small, dense HDL particles exert potent protection of atherogenic LDL against oxidative stress

Arteriosclerosis, thrombosis, and vascular biology, 2003-10, Vol.23 (10), p.1881-1888

2003

Volltextzugriff (PDF)

Why is HDL functionally deficient in type 2 diabetes?

Current diabetes reports, 2008-02, Vol.8 (1), p.51-59

2008

Volltextzugriff (PDF)

Reduced Capacity of High-Density Lipoprotein to Acquire Free Cholesterol From Triglyceride-Rich Lipoproteins Is Associated With Elevated Postprandial Hypertriglyceridemia in Healthy Men

Journal of the American Heart Association, 2024-08, Vol.13 (15), p.e034770

2024

Volltextzugriff (PDF)

HDL particle subpopulations: Focus on biological function

BioFactors (Oxford), 2015-03, Vol.41 (2), p.67-77

2015

Volltextzugriff (PDF)

Capacity of HDL to Efflux Cellular Cholesterol from Lipid-Loaded Macrophages Is Reduced in Patients with Familial Hypercholesterolemia

Metabolites, 2023-01, Vol.13 (2), p.197

2023

Volltextzugriff (PDF)

Vitamin E in Neurodegenerative Disorders: Alzheimer's Disease

Annals of the New York Academy of Sciences, 2004-12, Vol.1031 (1), p.249-262

2004

Volltextzugriff (PDF)

High-density lipoproteins (HDL): Novel function and therapeutic applications

Biochimica et biophysica acta. Molecular and cell biology of lipids, 2022-01, Vol.1867 (1), p.159058-159058, Article 159058

2022

Volltextzugriff (PDF)

Mathematical Modelling of Material Transfer to High-Density Lipoprotein (HDL) upon Triglyceride Lipolysis by Lipoprotein Lipase: Relevance to Cardioprotective Role of HDL

Metabolites, 2022-07, Vol.12 (7), p.623

2022

Volltextzugriff (PDF)

1 – 25 von 215

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(175)
Mit Volltextzugriff
(183)

Publikationsform

Artikel
(183)
Buchkapitel
(29)
Bücher
(3)

Sprache

Englisch
(215)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

HDL particle number and size as predictors of cardiovascular disease

Functionally defective high-density lipoprotein: a new therapeutic target at the crossroads of dyslipidemia, inflammation, and atherosclerosis

Antiatherogenic function of HDL particle subpopulations: focus on antioxidative activities

HDL and Reverse Remnant-Cholesterol Transport (RRT): Relevance to Cardiovascular Disease

Phosphatidylserine in atherosclerosis

Dysfunctional HDL and atherosclerotic cardiovascular disease

Cholesterol, Lipoproteins, and Cardiovascular Health: Separating the Good (HDL), the Bad (LDL), and the Remnant

HDL Particle Size Is a Critical Determinant of ABCA1-Mediated Macrophage Cellular Cholesterol Export

High-density lipoproteins: A consensus statement from the National Lipid Association

HDL-Targeting Therapeutics: Past, Present and Future

Pleiotropic effects of apolipoprotein C3 on HDL functionality and adipose tissue metabolic activity[S]

HDL Measures, Particle Heterogeneity, Proposed Nomenclature, and Relation to Atherosclerotic Cardiovascular Events

Antiatherogenic small, dense HDL-guardian angel of the arterial wall?

Circulating phospholipid profiling identifies portal contribution to NASH signature in obesity

Small dense HDLs display potent vasorelaxing activity, reflecting their elevated content of sphingosine-1-phosphate

Functionality of HDL: antioxidation and detoxifying effects

Apolipoprotein A-I structural organization in high-density lipoproteins isolated from human plasma

Small, dense HDL particles exert potent protection of atherogenic LDL against oxidative stress

Why is HDL functionally deficient in type 2 diabetes?

Reduced Capacity of High-Density Lipoprotein to Acquire Free Cholesterol From Triglyceride-Rich Lipoproteins Is Associated With Elevated Postprandial Hypertriglyceridemia in Healthy Men

HDL particle subpopulations: Focus on biological function

Capacity of HDL to Efflux Cellular Cholesterol from Lipid-Loaded Macrophages Is Reduced in Patients with Familial Hypercholesterolemia

Vitamin E in Neurodegenerative Disorders: Alzheimer's Disease

High-density lipoproteins (HDL): Novel function and therapeutic applications

Mathematical Modelling of Material Transfer to High-Density Lipoprotein (HDL) upon Triglyceride Lipolysis by Lipoprotein Lipase: Relevance to Cardioprotective Role of HDL

Suchergebnisse filtern